Labshake search
Citations for Stemcell Technologies :
51 - 100 of 1436 citations for 5 1 3 Dioxolan 2 yl 2 3 fluorobenzoyl thiophene since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Systems Biology 2024Quote: ... Cells were passaged 1:10 every 3 days using ReLeSR (StemCell Technologies #05873). Cells were maintained in a humidified incubator at 37°C with 5% CO2.
-
bioRxiv - Systems Biology 2024Quote: ... we passaged the cells at 1:3 using Accutase (STEMCELL Technologies, Cat#07920) and cultured cells in NPCs medium onwards.
-
bioRxiv - Cell Biology 2020Quote: ... and 3 units/mL EPO (STEMCELL Technologies) in the presence of 1 µM GSK-J4 (Sigma ...
-
bioRxiv - Physiology 2020Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies), 500 μg/mL BSA (Sigma Aldrich) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Interleukin-3 (IL3, StemCell Technologies, Cat#78194) and Interleukin-6 (IL6 ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD32 (STEMCELL Technologies; clone IV.3), anti-CD32B/C (clone S18005H) ...
-
bioRxiv - Microbiology 2020Quote: ... CHIR 99021 3 µM (Stemcell Technologies, 72054), Pumorphamine 1 µM (Miltenyi Biotec ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, cat#72054), 100 nM All-trans Retinoic acid (ATRA ...
-
bioRxiv - Systems Biology 2021Quote: ... 3 µM CHIR99021 (72054, Stem Cell Technologies) and 1 µM PD0325901 (72184 ...
-
bioRxiv - Cell Biology 2021Quote: ... 100μg/mL hrIL-3 (StemCell Technologies 78040), 10μg/mL hrG-CSF (NEUPOGEN ...
-
bioRxiv - Immunology 2022Quote: ... -32 (Stemcell Technologies 60012 clone IV.3), or -64 (Biolegend 305002 Clone 10.1).
-
bioRxiv - Genomics 2023Quote: ... 10 µg/mL NT-3 (StemCell Technologies), and 1 mg/mL Mouse Laminin (Gibco) ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3 µM CHIR99021 (STEMCELL Technologies, 72054), was freshly added ...
-
bioRxiv - Bioengineering 2022Quote: ... and 3 μM CHIR-99021 (Stemcell Technologies). After 4-day culture in SCM I ...
-
bioRxiv - Cell Biology 2023Quote: ... CHIR99021 (3 μM, STEMCELL Technologies, Cat#72052), purmorphamine (0.5 mM ...
-
bioRxiv - Cell Biology 2024Quote: ... and 3 U/mL heparin (StemCell Technologies) for differentiating progenitor cells into erythrocytes.
-
bioRxiv - Developmental Biology 2024Quote: ... 3 μM CHIR99021 (Stem Cell Technologies 72054) was included in the “Day 0 medium” and/or the concentration of BMP4 was reduced to 5 ng/mL (Figure 6C-E ...
-
bioRxiv - Developmental Biology 2024Quote: ... 50 ng/ml IL-3 (STEMCELL Technologies), 50 ng/ml IL-34 (Biolegend) ...
-
bioRxiv - Cancer Biology 2024Quote: ... mTeSR was changed every other day and cells were passaged every 3–5 days using ReLeaSR (StemCell Technologies #05872). All cell cultures were maintained in a humidified incubator with 5% CO2 at 37°C ...
-
bioRxiv - Biochemistry 2020Quote: ... containing 3 μM CHIR99021 (STEMCELL Technologies, Vancouver, Canada), 50 nM PI-103 from Bio-Techne Ltd ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 3 μM CHIR-99021 (Stem Cell Technologies), and then for the 3 following days to 100 ng/ml Activin A alone ...
-
bioRxiv - Immunology 2023Quote: ... Human Peripheral Blood Plasma (3%; Stem Cell Technologies), 3,3‘,5-Triiodo-L-thyronine (1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Canada), 500 μg.mL-1 bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, Vancouver, Canada, 72054), and 1 µM retinoic acid ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies; Cat. No. 72054), 2 μM DMH1 (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2024Quote: ... and Interleukin-3 (IL3, StemCell Technologies, Cat#78194) and Interleukin-6 (IL6 ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Phase 1 (S1, 3 days): Day 1 S1 medium + 100 ng/mL Activin A (StemCell Technologies, Cat# 78001) + 3 μM Chir99021 (Stemgent ...
-
bioRxiv - Neuroscience 2022Quote: ... IPSCs were cleaned and 1/3 dish was gently dissociated with dispase (Stemcell Technologies # 07923) for 12-15 minutes at 37°C ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were suspended in Hanks Balanced Salt Solution (HBSS) supplemented with 5% human serum and 1.5 µg/mL anti-human CD32 antibody (Clone IV.3; STEMCELL Technologies) and then stained with designated antibodies for 1-2 hours on ice prior to sorting on a Becton Dickinson FACSAria™ Fusion or FACSAria™ III sorter ...
-
bioRxiv - Developmental Biology 2022Quote: ... organoids were treated from days 3 - 5 with ROCKi-free neural differentiation medium supplemented with retinoic acid (RA) (Stemcell Technologies) at 0.25 μM and smoothened agonist (SAG ...
-
bioRxiv - Molecular Biology 2023Quote: ... Cardiomyocyte specification was completed by 3 days of culture in RPMI B27-media with 5 μM IWP-4 (STEMCELL Technologies), followed by another 7 days of culture with RPMI B27+ (RPMI 1640 GlutaMAX + 2% B27 supplement with insulin (ThermoFisher) ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Neuroscience 2023Quote: ... Each plate was then split 1:2 using ReLeSR (StemCell Technologies), with half of the cells used for DNA extraction for Sanger sequencing ...
-
bioRxiv - Bioengineering 2021Quote: ... T cells were frozen at 1-2 × 107 cells/mL and NK cells were frozen at 5 × 106 cells/mL in CryoStor CS10 (STEMCELL Technologies, Cambridge, MA) and thawed into culture as needed ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR librariesbioRxiv - Bioengineering 2020Quote: ... cells were maintained on 6-well plates in a humidified incubator at 37°C with 5% CO2 and passaged every 3-4 days (at ∼80% confluence) using ReLeSR (Stemcell Technologies), following the manufacturer’s protocol ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin (Thermo Fisher ...
-
bioRxiv - Cancer Biology 2021Quote: ... containing 3 mL Methocult GF H4230 (Stem Cell Technologies) and plated in triplicate in 35 mm gridded plates and incubating for 8-10 d.
-
bioRxiv - Immunology 2023Quote: ... and IL-3 (10 ng/mL; Stem Cell Technologies). After 5 days ...
-
bioRxiv - Microbiology 2024Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2023Quote: ... for 5-7 days and embedded into 2 mg/ml collagen type-I (StemCell Technologies, Vancouver, Canada) gels ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged 1-2 times per week with ReLeSR (STEMCELL Technologies) when they reached 80-90% confluence ...
-
bioRxiv - Genomics 2024Quote: ... cells were resuspended with 1-2 mL Dispase (Stem Cell Technologies, 07923) and 200 µL 1mg/mL DNase I (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... and routinely split 1-2 times a week with ReLeSR (STEMCELL Technologies) without ROCKi (Y-27632 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Cell Biology 2020Quote: ... Neural rosettes were derived between day 3 to day 5 by addition of STEMdiffTM Neural Rosette Selection Reagent (05832, Stem Cell Technologies) for 45 mins-1 hr at 37oC ...
-
bioRxiv - Physiology 2024Quote: ... Cells were utilized between passages 20 and 80 and passaged every 3–5 days at a confluency of 85–100% using Accutase (STEMCELL Technologies, #07920). The cardiac differentiation protocol was performed as previously described 49 ...